Why the study?
Does polycystic ovary syndrome increase cardiovascular disease risk markers in women compared to controls?
Population
12,250 women (7,174 with polycystic ovary syndrome and 5,076 controls) from 130 data sets
Comparison
Polycystic ovary syndrome (PCOS) (exposure) vs Controls (women without PCOS)
Design
Meta-analysis
Authors
Loading...
May warrant closer CVD monitoring in PCOS; confirms association with adverse biomarkers and extends evidence for heightened risk.
Does polycystic ovary syndrome increase cardiovascular disease risk markers in women compared to controls?
Women with PCOS have significantly elevated serum concentrations of multiple cardiovascular disease risk markers compared to controls, suggesting a potential increased risk for future cardiovascular disease.
Toulis et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: